LONDON: British officials and ministers sought to shore up confidence in AstraZeneca's COVID-19 vaccine on Thursday, saying advice that most people under 30 should be offered alternative shots was not unusual and would not impact the pace of rollout.
A pharmacist whose brother died from a brain blood clot linked to the AstraZeneca shot was among those calling for people to keep getting it, saying the doses would save lives.
Officials said the suggestion that under-30s should be offered an alternative did not reflect any serious safety concerns, just a "vanishingly" rare possible side effect.
Anthony Harnden, Deputy Chairman of the Joint Committee on Vaccination and Immunisation (JCVI) which issued the new advice, said such suggestions were not unusual, pointing out that people of different ages already got different flu shots in Britain.
"This isn't unusual. So this is not undermining what the regulators are saying. The regulators are saying this vaccine is suitable for all age groups but it's up to the individual countries to decide how best to deploy those vaccines," he told Reuters in an interview.
While Britain's MHRA medicine regulator did not place age restrictions on the use of the AstraZeneca shot, some saw the JCVI's advice about under-30s, made in the same briefing, as mixed messaging.
Conservative lawmaker Iain Duncan Smith said the announcement was "ridiculous" and that there was "the dangerous potential" that people would refuse to have AstraZeneca's shot.
Health minister Matt Hancock defended the move, saying the transparency over possible side effects, even very rare ones, should bolster confidence in the system.
Britain has continued to use its homegrown AstraZeneca vaccine since it became the first country to start rolling it out at the start of January. Some countries in Europe, including France, restricted its use in older people initially, citing a lack of data, and are now limiting its use in older people.
Harnden said Wednesday's announcement had not been taken lightly and it had been right to keep using the shot, even if the advice was now changing.
"Stopping and starting and changing vaccination programmes is not an easy thing to do, and if you do it, it runs the danger of losing confidence in that programme," he said.
STILL ON TRACK
Britain is leaning on AstraZeneca for a large portion of its vaccine supply, with 100 million doses ordered.
But it has also has been rolling out vaccines made by Pfizer, since December, and Moderna since Wednesday. Shots made by Johnson & Johnson and Novavax are also pending regulatory approval in the coming months.
Hancock said that with 40 million Pfizer and 17 million Moderna vaccines ordered, there was more than enough shots to cover the 8.5 million people under-30s who needed to be vaccinated. Healthy under-30s are in the last priority cohort to be vaccinated, with most not eligible until the summer.
"We feel that we've got enough vaccine supply to be able to offer (an) alternative vaccine, without delaying the progress of our immunisations," JCVI's Harnden said, adding Britain was on track to give a first shot of vaccine to all adults by the end of July.
"It may slip by a week or two, but no more than that," he said.
The advice did not change for under-30s who have underlying conditions and are eligible for shots now, meaning only very few people who are due to have a shot in the coming days will be affected by the advice change.
Alison Astles, a pharmacist whose 59-year-old brother died of a blood clot on the brain on Sunday, encouraged people to still get their AstraZeneca shots even though it was "very strongly suggested" his death was due to the shot.
"The sister in me still feels absolutely furious and very angry that this has happened to my brother... But despite what has happened to Neil, and the impact on our family, I still strongly believe that people should go ahead and have the vaccine," she said.
"Overall, we will save more lives by people having the vaccine than not."
Reuters
Fri Apr 09 2021
Alison Astles, a pharmacist whose 59-year-old brother died of a blood clot on the brain on Sunday, encouraged people to still get their AstraZeneca shots even though it was "very strongly suggested" his death was due to the shot. REUTERSpic
PRK: Ramanan nasihat calon fokus bertumpu bawa isu tempatan
Calon bertanding pada PRK DUN KKB perlu memberi tumpuan terhadap isu-isu yang dihadapi masyarakat tempatan berbanding membincangkan hal-hal bersifat nasional dalam siri kempen mereka.
Terengganu rekod lima kes strok haba, kelesuan haba
Sebanyak tiga kes strok haba dan dua kes kelesuan haba dilaporkan berlaku di Terengganu setakat bulan lepas.
Panasonic Beauty perkenal pengering rambut berteknologi nano, EH-NA0J
Teknologi unik nanoe MOISTURE dan Mineral memberi 18 kali lebih kelembapan sambil mengeringkan untuk rambut lebih terurus dan bersinar.
Angka korban rakyat Palestin di Gaza hampiri 34,600 orang
Angka kematian warga Palestin akibat serangan berterusan Israel di Semenanjung Gaza sejak Oktober lepas telah meningkat kepada 34,596 orang, kata Kementerian Kesihatan di wilayah itu pada Khamis.
Kemenangan di PRK KKB akan jadi manifestasi perpaduan - Ahmad Maslan
Kemenangan calon PH pada PRK DUN KKB, 11 Mei ini akan menjadi manifestasi perpaduan BN dan PH dalam menghadapi PRK lain, sekiranya diadakan pada masa depan.
Piala Thomas: Malaysia jinakkan Jepun untuk mara ke separuh akhir
Malaysia mara ke separuh akhir Piala Thomas 2024 selepas menundukkan Jepun 3-1 dalam perlawanan yang berlangsung di Gimnasium Pusat Sukan Hi-Tech, Chengdu, China.
Pembinaan Hospital Angkatan Tentera Kem Terendak bermula Julai ini
Pembinaan bangunan baharu Hospital Angkatan Tentera Kem Terendak di sini akan bermula pada Julai depan dan dijangka siap pada 2028, menurut Menteri Pertahanan Datuk Seri Mohamed Khaled Nordin.
Saifuddin Nasution akui perlu baiki isu di pintu masuk negara, bakal umum perubahan
Menteri Dalam Negeri Datuk Seri Saifuddin Nasution Ismail mengakui terdapat ruang yang boleh ditambah baik berhubung isu kesesakan di pintu masuk negara.
Program MADANI Rakyat 2024 Zon Utara bermula esok, 196 perkhidmatan disediakan
Platform untuk memberi peluang kepada masyarakat setempat memahami dan menilai dasar serta inisiatif baharu dilaksanakan kerajaan.
AWANI 7:45 [02/05/2024] - Jaminan lulus dengan bergaya | Reformasi sistem pendidikan | RM10.5 bilion tempoh empat tahun | Fail afidavit betulkan fakta
#AWANI745 malam ini bersama Jasmine Abu Bakar;
1. Humban siapa yang bantah kenaikan gaji penjawat awam
2. Sebelum Bank Dunia lapor, kementerian sudah ambil tindakan, kata Fadhlina
3. Microsoft labur RM10.5 bilion, peluang generasi muda teroka keselamatan siber
4. Mahkamah Tinggi tolak permohonan Tengku Zafrul
1. Humban siapa yang bantah kenaikan gaji penjawat awam
2. Sebelum Bank Dunia lapor, kementerian sudah ambil tindakan, kata Fadhlina
3. Microsoft labur RM10.5 bilion, peluang generasi muda teroka keselamatan siber
4. Mahkamah Tinggi tolak permohonan Tengku Zafrul
Kesan sampingan vaksin: KKM akan dapatkan penjelasan AstraZeneca
Kementerian Kesihatan (KKM) akan mendapatkan penjelasan daripada firma farmaseutikal AstraZeneca berhubung kesan sampingan vaksin COVID-19 seperti yang dilaporkan media antarabangsa baru-baru ini.
AstraZeneca berjaya batalkan saman 12 individu berhubung isu suntikan vaksin COVID-19
Hakim Mahkamah Tinggi Dr Suzana Muhamad Said membenarkan permohonan Astrazeneca untuk membatalkan saman itu selepas mendengar hujahan kedua-dua pihak.
AstraZeneca rintis inisiatif kesaksamaan akses dalam perkhidmatan kesihatan
Portal mySihatPal menutup jurang akses kepada penyelesaian penjagaan kesihatan.
AstraZeneca tumpu kepada kepada penyakit jarang jumpa, teruskan pelaburan tempatan
AstraZeneca berhasrat menjadi pengupaya penyelesaian yang bekerjasama dalam aspek berbeza kepada pesakit.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
WEF2023: Tengku Zafrul bertemu lembaga pengarah AstraZeneca
Pertemuan itu berkisar mengenai potensi untuk AstraZeneca meluaskan operasi di Malaysia.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
Mana-mana vaksin penggalak lebih baik dari tiada - Khairy
Walaupun Kementerian Kesihatan (KKM) menyarankan dos penggalak Pfizer atau AstraZeneca untuk memberi tambahan perlindungan yang terbaik, ada masyarakat yang masih meminta pilihan.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
Pencipta AstraZeneca, GAVI terima Hadiah Keamanan Sunhak 2022
Pengiktirafan tersebut diberikan atas sumbangan signifikan yang diberikan mereka dalam membantu dunia menghadapi pandemik COVID-19.